https://www.selleckchem.com/products/Eloxatin.html
This study evaluates a long-acting liposomal fluorescence / CT dual-modality contrast agent (CF80 in head and neck cancer to enhance intraoperative tumor demarcation with fluorescence imaging and cone-beam computed tomography (CBCT). CF800 was administered to 12 buccal cancer-bearing rabbits. Imaging was acquired at regular time points to quantify time-dependent contrast enhancement. Surgery was performed 5-7 days after, with intraoperative near-infrared fluorescence endoscopy and CBCT, followed by histological and ex-vivo fluorescen
Like
Comment
Share
